Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Bio-Rad Laboratories (BIO)

Bio-Rad Laboratories (BIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,168,174
  • Shares Outstanding, K 27,997
  • Annual Sales, $ 2,671 M
  • Annual Income, $ -637,320 K
  • EBIT $ 306 M
  • EBITDA $ 306 M
  • 60-Month Beta 0.90
  • Price/Sales 3.42
  • Price/Cash Flow 26.92
  • Price/Book 1.22

Options Overview Details

View History
  • Implied Volatility 33.58% ( -1.65%)
  • Historical Volatility 41.42%
  • IV Percentile 40%
  • IV Rank 31.13%
  • IV High 48.40% on 10/30/24
  • IV Low 26.88% on 11/15/24
  • Put/Call Vol Ratio 0.82
  • Today's Volume 40
  • Volume Avg (30-Day) 10
  • Put/Call OI Ratio 1.16
  • Today's Open Interest 577
  • Open Int (30-Day) 559

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 2.88
  • Number of Estimates 2
  • High Estimate 2.98
  • Low Estimate 2.79
  • Prior Year 3.10
  • Growth Rate Est. (year over year) -7.10%

Price Performance

See More
Period Period Low Period High Performance
1-Month
318.27 +2.89%
on 12/19/24
351.08 -6.72%
on 12/17/24
+3.78 (+1.17%)
since 11/20/24
3-Month
306.42 +6.87%
on 11/18/24
387.99 -15.60%
on 11/06/24
-2.54 (-0.77%)
since 09/20/24
52-Week
262.12 +24.93%
on 07/02/24
387.99 -15.60%
on 11/06/24
+19.16 (+6.21%)
since 12/20/23

Most Recent Stories

More News
How Is Thermo Fisher Scientific’s Stock Performance Compared to Other Medical Devices Stocks?

While Thermo Fisher Scientific has underperformed the broader medical device industry recently, analysts remain optimistic about the company's future outlook.

TMO : 524.05 (+1.42%)
BIO : 327.47 (+0.47%)
MDEV : 20.76 (+1.16%)
BIO Q3 Earnings and Revenues Surpass Estimates, Stock Up Aftermarket

Bio-Rad Laboratories, Inc. BIO posted third-quarter 2024 adjusted earnings per share (EPS) of $2.01, which beat the Zacks Consensus Estimate by 57%. However, the bottom line decreased 13.7% from the prior-year...

VCYT : 40.89 (+4.66%)
HQY : 94.95 (+0.20%)
BIO : 327.47 (+0.47%)
PAHC : 21.69 (-0.55%)
Bio-Rad: Q3 Earnings Snapshot

Bio-Rad: Q3 Earnings Snapshot

BIO : 327.47 (+0.47%)
Bio-Rad: Q3 Earnings Snapshot

Bio-Rad: Q3 Earnings Snapshot

BIO : 327.47 (+0.47%)
BIO Gears Up for Q3 Earnings: Here's What You Need to Know

Bio-Rad Laboratories, Inc. BIO is scheduled to release third-quarter 2024 results on Oct. 30, after the closing bell.The company posted adjusted earnings per share (EPS) of $3.11 in the last reported...

AVIR : 3.19 (+1.92%)
BIO : 327.47 (+0.47%)
TMDX : 61.70 (+1.93%)
RDNT : 72.70 (+1.85%)
Stocks Settle Higher on Positive Corporate Earnings Results

The S&P 500 Index ($SPX ) (SPY ) Wednesday closed up by +0.47%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up by +0.79%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up by +0.07%. Stocks...

UAL : 97.40 (+1.93%)
A : 134.51 (+0.99%)
CSCO : 58.52 (+1.54%)
AVY : 188.13 (+1.00%)
CFG : 43.45 (+2.36%)
PENG : 18.51 (+0.82%)
$IUXX : 21,289.15 (+0.85%)
FHN : 19.94 (+3.48%)
DHR : 228.55 (+1.06%)
ASML : 705.68 (-0.64%)
ZNH25 : 108-310s (+0.33%)
$DOWI : 42,840.26 (+1.18%)
Should You Continue to Hold Bio-Rad Stock in Your Portfolio?

Bio-Rad Laboratories, Inc.’s BIO robust QX600 Droplet Digital PCR (ddPCR) platform positions the company well to capture a major share in the booming digital PCR space. The clinical diagnostics business...

AXGN : 15.64 (+5.32%)
BIO : 327.47 (+0.47%)
PAHC : 21.69 (-0.55%)
TMDX : 61.70 (+1.93%)
Bio-Rad Laboratories Stock: Is BIO Underperforming the Healthcare Sector?

Despite Bio-Rad Laboratories’ underperformance relative to the healthcare sector over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

XLV : 138.00 (+1.26%)
BIO : 327.47 (+0.47%)
QGEN : 44.67 (+0.79%)
S&P 500 Shake-Up: New Entrants Driving Market Momentum

The quarterly rebalancing of the S&P 500 reflects market capitalization and performance shifts, highlighting growth and challenges in multiple sectors.

ETSY : 56.81 (-0.58%)
ERIE : 416.48 (+1.98%)
BIO : 327.47 (+0.47%)
AAL : 16.88 (+1.44%)
DELL : 115.77 (+3.40%)
PLTR : 80.55 (+8.54%)
Palantir Stock Will Join the S&P 500 in September. History Says It Could Soar Afterward.

History says Palantir stock could soar after its inclusion in the S&P 500.

BIO : 327.47 (+0.47%)
DELL : 115.77 (+3.40%)
AI : 36.34 (+2.51%)
GOOGL : 191.41 (+1.54%)
ERIE : 416.48 (+1.98%)
AAL : 16.88 (+1.44%)
GOOG : 192.96 (+1.72%)
ETSY : 56.81 (-0.58%)
$SPX : 5,930.85 (+1.09%)
PLTR : 80.55 (+8.54%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and...

See More

Key Turning Points

3rd Resistance Point 340.85
2nd Resistance Point 337.48
1st Resistance Point 332.47
Last Price 327.47
1st Support Level 324.09
2nd Support Level 320.72
3rd Support Level 315.71

See More

52-Week High 387.99
Fibonacci 61.8% 339.91
Last Price 327.47
Fibonacci 50% 325.05
Fibonacci 38.2% 310.20
52-Week Low 262.12

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar